{"date":"2026-09-23","count":27,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7808-2026-09-23-2006-10dtv8v","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"20:06:50","subject":"本公司向關係人取得不動產使用權資產(補充公告)","clause":"第17款","fact_date":"2026-03-04","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-09-23 20:06，「本公司向關係人取得不動產使用權資產(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2026-09-23-1920-110qxml","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"19:20:41","subject":"公告本公司取得會計師內部控制制度專案審查報告","clause":"第25款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2026-09-23 19:20，「公告本公司取得會計師內部控制制度專案審查報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-09-23-1853-1nuha4r","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-09-23","time":"18:53:20","subject":"公告本公司最近一年累積處分有價證券達公告標準","clause":"第20款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-09-23 18:53，「公告本公司最近一年累積處分有價證券達公告標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2026-09-23-1708-15hj0yh","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"17:08:13","subject":"(更正文字)公告LXP105應用於第二期三陰性乳癌(Triple-Negative Breast Cancer, TNBC）新輔助治療的探索性臨床研究，獲國際腫瘤學期刊《Frontiers in Oncology》接受並準備發表。","clause":"第44款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2026-09-23 17:08，「(更正文字)公告LXP105應用於第二期三陰性乳癌(Triple-Negative Breast Cancer, TNB」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-09-23-1544-1178zgq","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"15:44:45","subject":"公告本公司董事長決議向金融監督管理委員會申請調整每股發行價格","clause":"第44款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-09-23 15:44，「公告本公司董事長決議向金融監督管理委員會申請調整每股發行價格」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-09-23-1544-1v210mx","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"15:44:09","subject":"公告本公司申請延長現金增資發行普通股乙案之募集期間業經金管會准予備查","clause":"第44款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-09-23 15:44，「公告本公司申請延長現金增資發行普通股乙案之募集期間業經金管會准予備查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7876-2026-09-23-1542-1wpawso","company_id":"7876","company":"鼎晉生技","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"15:42:40","subject":"公告本公司現金增資認股基準日等相關事宜","clause":"第9款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：鼎晉生技（7876），2026-09-23 15:42，「公告本公司現金增資認股基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-09-23-1540-8dqhff","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:40:59","subject":"本公司董事會決議發行限制員工權利新股之增資基準日","clause":"第51款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-09-23 15:40，「本公司董事會決議發行限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-09-23-1540-1udn163","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:40:32","subject":"公告本公司董事會通過內部稽核主管委任","clause":"第8款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-09-23 15:40，「公告本公司董事會通過內部稽核主管委任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-09-23-1540-eem50","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:40:10","subject":"公告本公司公司治理主管及代理發言人異動","clause":"第8款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-09-23 15:40，「公告本公司公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-09-23-1538-1kc6790","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:38:44","subject":"代子公司「蘇州中化藥品工業有限公司」公告法人董事改派代表人暨董事變動達三分之一。","clause":"第6款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-09-23 15:38，「代子公司「蘇州中化藥品工業有限公司」公告法人董事改派代表人暨董事變動達三分之一。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-09-23-1537-d8timo","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:37:39","subject":"代子公司「蘇州中化藥品工業有限公司」公告改派董事長","clause":"第6款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-09-23 15:37，「代子公司「蘇州中化藥品工業有限公司」公告改派董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-09-23-1537-179rsib","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:37:11","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告董事會選任董事長","clause":"第6款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-09-23 15:37，「代子公司CARLSBAD TECHNOLOGY, INC.公告董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-09-23-1537-1dgvjpk","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"15:37:08","subject":"公告本公司股票初次上市現金增資股款委託代收及存儲價款機構","clause":"第44款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-09-23 15:37，「公告本公司股票初次上市現金增資股款委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-09-23-1536-mt5la8","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:36:55","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告2025年度現金股利配發基準日","clause":"第14款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-09-23 15:36，「代子公司CARLSBAD TECHNOLOGY, INC.公告2025年度現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-09-23-1536-1e3ik1o","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:36:37","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告2026年股東常會改選董事","clause":"第6款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-09-23 15:36，「代子公司CARLSBAD TECHNOLOGY, INC.公告2026年股東常會改選董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-09-23-1536-118sbcl","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"15:36:16","subject":"代子公司CARLSBAD TECHNOLOGY,INC.公告股東會重要決議事項","clause":"第18款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-09-23 15:36，「代子公司CARLSBAD TECHNOLOGY,INC.公告股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2026-09-23-1502-yoeqno","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"15:02:03","subject":"本公司與泰國Biogenetech公司簽訂腸病毒疫苗獨家經銷合約書","clause":"第8款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2026-09-23 15:02，「本公司與泰國Biogenetech公司簽訂腸病毒疫苗獨家經銷合約書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2026-09-23-1433-r5u7d5","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"14:33:44","subject":"本公司受邀參加法人說明會","clause":"第12款","fact_date":"2026-09-24","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2026-09-23 14:33，「本公司受邀參加法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2026-09-23-1424-1cza5x2","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2026-09-23","time":"14:24:12","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"第53款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2026-09-23 14:24，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-09-23-1358-kxgk3x","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"13:58:00","subject":"公告本公司發言人及代理發言人異動","clause":"第8款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-09-23 13:58，「公告本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-09-23-1348-1msnnl2","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-09-23","time":"13:48:24","subject":"代重要子公司Medic Vision AI Limited公告董事改選當選名單","clause":"第6款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-09-23 13:48，「代重要子公司Medic Vision AI Limited公告董事改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-09-23-1346-r9wxet","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-09-23","time":"13:46:26","subject":"代重要子公司Medic Vision AI Limited公告股東會決議事項","clause":"第18款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-09-23 13:46，「代重要子公司Medic Vision AI Limited公告股東會決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-09-23-1339-1xf4loc","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"13:39:00","subject":"公告本公司營運長人事異動","clause":"第8款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-09-23 13:39，「公告本公司營運長人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-09-23-1213-1fybnjr","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-09-23","time":"12:13:26","subject":"公告本公司115年8月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-09-23 12:13，「公告本公司115年8月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-09-23-1147-1ch2b8n","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-09-23","time":"11:47:35","subject":"澄清媒體報導內容","clause":"第51款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-09-23 11:47，「澄清媒體報導內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-09-23-0827-r7sop7","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-09-23","time":"08:27:45","subject":"公告本公司115年08月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第44款","fact_date":"2026-09-23","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-09-23 08:27，「公告本公司115年08月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}